The effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation

Basit Öğe Kaydı
dc.contributor.authorAkkaya, Ozgur
dc.contributor.authorKarahan, Oguz
dc.date.accessioned2026-01-24T12:26:47Z
dc.date.available2026-01-24T12:26:47Z
dc.date.issued2024
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractBackground: In the current guidelines, dual antiplatelet therapy [acetylsalicylic acid (ASA) + clopidogrel] is recommended for at least three months after peripheral iliac stenting. In this study, we investigated the effect on clinical outcomes of adding ASA in different doses and at different times after Methods: Seventy-one patients were administered dual antiplatelet therapy after successful iliac stenting. Group 1, consisting of 40 patients, was given 75 mg of clopidogrel plus 75 mg of ASA in a single dose in the morning. In group 2, separate doses of 75 mg of clopidogrel (in the morning) and 81 mg of 1 x 1 ASA (in the evening) were started in 31 patients after the procedure were recorded. resulting in reduced haemoglobin levels (p = 0.038). dose of ASA.
dc.identifier.doi10.5830/CVJA-2023-013
dc.identifier.endpage105
dc.identifier.issn1995-1892
dc.identifier.issn1680-0745
dc.identifier.issue2
dc.identifier.pmid37358899
dc.identifier.scopus2-s2.0-85203957991
dc.identifier.scopusqualityQ3
dc.identifier.startpage102
dc.identifier.urihttps://doi.org/10.5830/CVJA-2023-013
dc.identifier.urihttps://hdl.handle.net/20.500.12868/4933
dc.identifier.volume35
dc.identifier.wosWOS:001015870500001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherClinics Cardive Publ Pty Ltd
dc.relation.ispartofCardiovascular Journal of Africa
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260121
dc.subjectperipheral arterial revascularisation
dc.subjectdual antiplatelet therapy
dc.subjectacetylsalicylic acid dosing
dc.subjectoutcome
dc.subjectbleeding
dc.titleThe effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu